Compare Abeona Therapeutics Inc (ABEO) vs ProShares Ultra Bloomberg Natural Gas ETF (BOIL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while ProShares Ultra Bloomberg Natural Gas ETF trades at $26.66. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BOIL | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.23 | $98.62 |
52-Week Low | $4.17 | $24.30 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
BOIL trades at $26.65, up 0.79% today, but technical indicators signal a bearish trend with 14 sell signals versus 1 buy. The stock recently underwent a 1:2 split on May 28, 2026. Natural gas futures volatility, driven by weather forecasts and LNG demand, heavily influences price action. Key support sits at $25-26, with resistance at $27-28.
Outlook remains cautious due to technical weakness and reliance on volatile commodity prices. Investment opportunity exists for tactical traders betting on natural gas price swings, but risks include contango erosion and weather-dependent demand. Long-term value erosion is a significant concern given the ETF's structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ProShares Ultra Bloomberg Natural Gas ETF
BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →
